Panel Discussion | Stroke and Carotid Intervention

Sunday, March 9, 2025

3:12 PM - 3:40 PM ET

Moderator(s)

Herbert D. Aronow, MD, MPH

Medical Director, Heart & Vascular Services
Henry Ford Health
Detroit, Michigan, United States

No relationships to disclose
James Stephen Jenkins, MD

Section Head, Interventional Cardiology Director, Interventional Cardiology Research
Ochsner Medical Center
New Orleans, Louisiana, United States

No relationships to disclose

Panel Discussant(s)

Gholam Ali, MD, FACC, FSVM,FNLA

Medical Director of Vascular Lab
Tulane University Heart and Vascular Institute
New Orleans, Louisiana, United States

No relationships to disclose
John Fritz Angle, MD

Professor of Radiology
University of Virginia
Charlottesville, Virginia, United States

No relationships to disclose
J. Michael Bacharach, MD

Section Head, Vascular Medicine and Peripheral Vascular Intervention
North Central Heart Institute
Sioux Falls, South Dakota, United States

No relationships to disclose
Schuyler Jones, MD

Professor of Medicine
Duke University Health System
Durham, North Carolina, United States

Disclosure information not submitted.
Horst Sievert, MD, FSCAI, FACC, FESC

Director
CardioVascular Center Frankfurt CVC
Frankfurt, Hessen, Germany

No relationships to disclose
James P. Zidar, MD, FSCAI

Clinical Professor of Medicine
University of North Carolina/Rex Healthcare
Raleigh, North Carolina, United States

Disclosure information not submitted.

Disclosure(s):

Herbert D. Aronow, MD, MPH: Amplitude Vascular Systems: Consultant (Ongoing); Medtronic: Consultant (Ongoing); Novartis Pharmaceuticals: Consultant (Terminated); Rapid AI: Consultant (Ongoing)

James Stephen Jenkins, MD: Abbott Labs: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Gholam Ali, MD, FACC, FSVM,FNLA: No financial relationships to disclose

John Fritz Angle, MD: EndoRon Ltd: Consulting Fees (e.g., advisory boards) (Ongoing)

J. Michael Bacharach, MD: No financial relationships to disclose

Schuyler Jones, MD: No financial relationships to disclose

Horst Sievert, MD, FSCAI, FACC, FESC: Abbott, Ablative Solutions, Adona Medical, Akura Medical, Ancora Heart, Append Medical, Axon, Bavaria Medizin Technologie GmbH, BioRefine, Bioventrix, Boston Scientific, Canon, Cardiac Dimensions, Cardiac Success, Cardimed, Cardionovum, Contego: Study honoraria to institution, travel expenses, consulting fees (Ongoing); Coramaze, Croivalve, CSL Behring LLC, CVRx, Dinova, Endobar, Endologix, Endomatic, Esperion Therapeutics, Inc., Hangzhou Nuomao Medtech, Holistick Medical, Intershunt, Intervene, K2, Laminar, Lifetech: Study honoraria to institution, travel expenses, consulting fees (Ongoing); Magenta, Maquet Getinge Group, Metavention, Mitralix, Mokita, Myotec, Neurotronic, Novelrad, NXT Biomedical, Occlutech, Recor, Renal Guard, Shifamed, Terumo, Tonic Medical: Study honoraria to institution, travel expenses, consulting fees (Ongoing); Trisol, TruLeaf, Vascular Dynamics, Vectorious Medtech, Venus, Venock, Vivasure Medical, Vvital Biomed, Whiteswell, Xenter: Study honoraria to institution, travel expenses, consulting fees (Ongoing)

Michael Wholey, MD, MBA, FSCAI: No financial relationships to disclose

James P. Zidar, MD, FSCAI: CONTEGO MEDICAL: Consulting Fees (e.g., advisory boards) (Ongoing)